TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55 | -39.6% | 311 | 0.0% | 0.00% | – |
| Q2 2023 | $91 | -84.5% | 311 | 0.0% | 0.00% | – |
| Q1 2023 | $588 | +27.0% | 311 | 0.0% | 0.00% | – |
| Q4 2022 | $463 | -92.3% | 311 | -91.4% | 0.00% | – |
| Q3 2022 | $6,000 | -14.3% | 3,600 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 3,600 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +80.0% | 3,600 | +350.0% | 0.00% | – |
| Q2 2021 | $5,000 | -44.4% | 800 | -27.3% | 0.00% | – |
| Q1 2021 | $9,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
| Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
| Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
| JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
| X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |